{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T21:36:27Z","timestamp":1794864987511,"version":"4.9.1"},"reference-count":249,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:00:00Z","timestamp":1626307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY027881"],"award-info":[{"award-number":["EY027881"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HD018655"],"award-info":[{"award-number":["HD018655"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["MH104318"],"award-info":[{"award-number":["MH104318"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS066019"],"award-info":[{"award-number":["NS066019"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.neuropharm.2021.108719","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T01:11:46Z","timestamp":1626311506000},"page":"108719","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":380,"special_numbering":"C","title":["Glutamate metabolism and recycling at the excitatory synapse in health and neurodegeneration"],"prefix":"10.1016","volume":"196","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8767-2675","authenticated-orcid":false,"given":"Jens V.","family":"Andersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9446-0400","authenticated-orcid":false,"given":"Kia H.","family":"Markussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emil","family":"Jakobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Schousboe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helle S.","family":"Waagepetersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5027-1218","authenticated-orcid":false,"given":"Blanca I.","family":"Aldana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2021.108719_bib1","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1523\/JNEUROSCI.4042-03.2004","article-title":"Beta-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase","volume":"24","author":"Abramov","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108719_bib2","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1002\/jnr.24075","article-title":"Astrocyte dysfunction in Alzheimer disease","volume":"95","author":"Acosta","year":"2017","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2021.108719_bib3","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1523\/JNEUROSCI.5098-09.2010","article-title":"Amyloid-beta aggregates cause alterations of astrocytic metabolic phenotype: impact on neuronal viability","volume":"30","author":"Allaman","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108719_bib4","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1002\/jnr.24038","article-title":"Specificity of exogenous acetate and glutamate as astrocyte substrates examined in acute brain slices from female mice using methionine sulfoximine (MSO) to inhibit glutamine synthesis","volume":"95","author":"Andersen","year":"2017","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2021.108719_bib5","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2107084","article-title":"Impaired hippocampal glutamate and glutamine metabolism in the db\/db mouse model of type 2 diabetes mellitus","volume":"2017","author":"Andersen","year":"2017","journal-title":"Neural Plast."},{"key":"10.1016\/j.neuropharm.2021.108719_bib6","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1007\/s00018-019-03051-2","article-title":"Enhanced cerebral branched-chain amino acid metabolism in R6\/2 mouse model of Huntington's disease","volume":"76","author":"Andersen","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuropharm.2021.108719_bib7","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1002\/glia.23872","article-title":"Extensive astrocyte metabolism of \u03b3-aminobutyric acid (GABA) sustains glutamine synthesis in the mammalian cerebral cortex","volume":"68","author":"Andersen","year":"2020","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2021.108719_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105198","article-title":"Deficient astrocyte metabolism impairs glutamine synthesis and neurotransmitter homeostasis in a mouse model of Alzheimer's disease","volume":"148","author":"Andersen","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2021.108719_bib9","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/jnr.490180207","article-title":"Glial glutamate dehydrogenase: ultrastructural localization and regional distribution in relation to the mitochondrial enzyme, cytochrome oxidase","volume":"18","author":"Aoki","year":"1987","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2021.108719_bib10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nn1609","article-title":"Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse","volume":"9","author":"Aoyama","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108719_bib11","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1073\/pnas.94.8.4155","article-title":"Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance","volume":"94","author":"Arriza","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2021.108719_bib12","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/00004647-200110000-00001","article-title":"An energy budget for signaling in the grey matter of the brain","volume":"21","author":"Attwell","year":"2001","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.neuropharm.2021.108719_bib13","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1471-4159.2006.03913.x","article-title":"The glutamate\/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer","volume":"98","author":"Bak","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2021.108719_bib14","doi-asserted-by":"crossref","first-page":"13929","DOI":"10.1523\/JNEUROSCI.4413-09.2009","article-title":"Transgenic expression of Glud1 (glutamate dehydrogenase 1) in neurons: in vivo model of enhanced glutamate release, altered synaptic plasticity, and selective neuronal vulnerability","volume":"29","author":"Bao","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108719_bib15","doi-asserted-by":"crossref","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat Rev Dis Prim."},{"key":"10.1016\/j.neuropharm.2021.108719_bib16","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.neuint.2012.01.013","article-title":"The glutamate transporter, GLAST, participates in a macromolecular complex that supports glutamate metabolism","volume":"61","author":"Bauer","year":"2012","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2021.108719_bib17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ana.410310202","article-title":"Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?","volume":"31","author":"Beal","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108719_bib18","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/brain\/awf180","article-title":"Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation","volume":"125","author":"Behrens","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2021.108719_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105172","article-title":"What are activated and reactive glia and what is their role in neurodegeneration?","volume":"148","author":"Bennett","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2021.108719_bib20","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1471-4159.1977.tb10703.x","article-title":"Huntington's chorea: post mortem activity of enzymes involved in cerebral glucose metabolism","volume":"29","author":"Bird","year":"1977","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2021.108719_bib21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/jnc.14829","article-title":"The energetic brain - a review from students to students","volume":"151","author":"Bordone","year":"2019","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2021.108719_bib22","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/jcbfm.2014.110","article-title":"Impaired brain energy metabolism in the BACHD mouse model of Huntington's disease: critical role of astrocyte-neuron interactions","volume":"34","author":"Boussicault","year":"2014","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.neuropharm.2021.108719_bib23","series-title":"Cortex: Statistics and Geometry of Neuronal Connectivity","author":"Braitenberg","year":"1998"},{"key":"10.1016\/j.neuropharm.2021.108719_bib24","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/327707a0","article-title":"Electrogenic glutamate uptake is a major current carrier in the membrane of axolotl retinal glial cells","volume":"327","author":"Brew","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2021.108719_bib25","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1023\/B:NERE.0000014824.04728.dd","article-title":"The energetics of Huntington's disease","volume":"29","author":"Browne","year":"2004","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2021.108719_bib26","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/jnr.24810","article-title":"Entering a new era of quantifying glutamate clearance in health and disease","volume":"99","author":"Brymer","year":"2021","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2021.108719_bib27","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/0896-6273(89)90240-7","article-title":"Synaptic vesicles immunoisolated from rat cerebral cortex contain high levels of glutamate","volume":"3","author":"Burger","year":"1989","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2021.108719_bib28","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2015.0429","article-title":"Impairments of neural circuit function in Alzheimer's disease","volume":"371","author":"Busche","year":"2016","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.neuropharm.2021.108719_bib29","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1126\/science.1162844","article-title":"Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease","volume":"321","author":"Busche","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2021.108719_bib30","doi-asserted-by":"crossref","first-page":"8740","DOI":"10.1073\/pnas.1206171109","article-title":"Critical role of soluble amyloid-beta for early hippocampal hyperactivity in a mouse model of Alzheimer's disease","volume":"109","author":"Busche","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2021.108719_bib31","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.15252\/embj.201695810","article-title":"Brain metabolism in health, aging, and neurodegeneration","volume":"36","author":"Camandola","year":"2017","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2021.108719_bib32","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/bpa.12402","article-title":"Alzheimer's disease: from mitochondrial perturbations to mitochondrial medicine","volume":"26","author":"Cardoso","year":"2016","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neuropharm.2021.108719_bib33","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/0024-3205(82)90090-X","article-title":"Glutamine synthetase activity in Huntington's disease","volume":"31","author":"Carter","year":"1982","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2021.108719_bib34","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.cell.2015.07.022","article-title":"A call for systematic research on solute carriers","volume":"162","author":"C\u00e9sar-Razquin","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2021.108719_bib35","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0092-8674(00)81674-8","article-title":"Molecular analysis of system N suggests novel physiological roles in nitrogen metabolism and synaptic transmission","volume":"99","author":"Chaudhry","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2021.108719_bib36","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1523\/JNEUROSCI.22-01-00062.2002","article-title":"Glutamine uptake by neurons: interaction of protons with system a transporters","volume":"22","author":"Chaudhry","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108719_bib37","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1523\/JNEUROSCI.1586-03.2004","article-title":"The glutamate transporter GLT1a is expressed in excitatory axon terminals of mature hippocampal neurons","volume":"24","author":"Chen","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108719_bib38","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jnutbio.2015.12.001","article-title":"Metabolic disturbances in plasma as biomarkers for Huntington's disease","volume":"31","author":"Cheng","year":"2016","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.neuropharm.2021.108719_bib39","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0896-6273(88)90162-6","article-title":"Glutamate neurotoxicity and diseases of the nervous system","volume":"1","author":"Choi","year":"1988","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2021.108719_bib40","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1038\/cddis.2010.68","article-title":"Alterations of brain and cerebellar proteomes linked to A\u03b2 and tau pathology in a female triple-transgenic murine model of Alzheimer's disease","volume":"1","author":"Ciavardelli","year":"2010","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuropharm.2021.108719_bib41","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.neuint.2005.11.016","article-title":"The glutamine commute: lost in the tube?","volume":"48","author":"Conti","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2021.108719_bib42","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10522-020-09860-4","article-title":"Alzheimer's disease: targeting the glutamatergic system","volume":"21","author":"Conway","year":"2020","journal-title":"Biogerontology"},{"key":"10.1016\/j.neuropharm.2021.108719_bib43","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-3-319-45096-4_5","article-title":"BCAA metabolism and NH3 homeostasis","volume":"13","author":"Conway","year":"2016","journal-title":"Adv Neurobiol"},{"key":"10.1016\/j.neuropharm.2021.108719_bib44","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/s41573-020-0072-x","article-title":"Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing","volume":"19","author":"Cunnane","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2021.108719_bib45","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0026-895X(25)08949-7","article-title":"Selectivity of amino acid transmitters acting at N-methyl-D-aspartate and amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors","volume":"41","author":"Curras","year":"1992","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108719_bib46","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1471-4159.1960.tb13458.x","article-title":"The excitation and depression of spinal neurones by structurally related amino acids","volume":"6","author":"Curtis","year":"1960","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2021.108719_bib47","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1113\/jphysiol.1960.sp006410","article-title":"The chemical excitation of spinal neurones by certain acidic amino acids","volume":"150","author":"Curtis","year":"1960","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2021.108719_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-0082(00)00067-8","article-title":"Glutamate uptake","volume":"65","author":"Danbolt","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2021.108719_bib49","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuint.2016.05.009","article-title":"Neuronal vs glial glutamate uptake: resolving the conundrum","volume":"98","author":"Danbolt","year":"2016","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2021.108719_bib50","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41419-020-02911-1","article-title":"Proteomic analysis links alterations of bioenergetics, mitochondria-ER interactions and proteostasis in hippocampal astrocytes from 3xTg-AD mice","volume":"11","author":"Dematteis","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuropharm.2021.108719_bib51","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cmet.2017.06.021","article-title":"Neuronal stimulation triggers neuronal glycolysis and not lactate uptake","volume":"26","author":"Diaz-Garcia","year":"2017","journal-title":"Cell Metabol."},{"key":"10.1016\/j.neuropharm.2021.108719_bib52","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1002\/jnr.24015","article-title":"Lack of appropriate stoichiometry: strong evidence against an energetically important astrocyte-neuron lactate shuttle in brain","volume":"95","author":"Dienel","year":"2017","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2021.108719_bib53","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1152\/physrev.00062.2017","article-title":"Brain glucose metabolism: integration of energetics with function","volume":"99","author":"Dienel","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2021.108719_bib54","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.047134","article-title":"Ammonia inhibits energy metabolism in astrocytes in a rapid and glutamate dehydrogenase 2-dependent manner","volume":"13","author":"Drews","year":"2020","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.neuropharm.2021.108719_bib55","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1093\/brain\/awn133","article-title":"Recurrent seizures and brain pathology after inhibition of glutamine synthetase in the hippocampus in rats","volume":"131","author":"Eid","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2021.108719_bib56","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1042\/bj1050691","article-title":"The equilibrium constants of the glutamate dehydrogenase systems","volume":"105","author":"Engel","year":"1967","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuropharm.2021.108719_bib57","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/jnc.14046","article-title":"Functional identification of activity-regulated, high-affinity glutamine transport in hippocampal neurons inhibited by riluzole","volume":"142","author":"Erickson","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2021.108719_bib58","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.arcmed.2007.11.011","article-title":"Excitotoxic neuronal death and the pathogenesis of Huntington's disease","volume":"39","author":"Estrada S\u00e1nchez","year":"2008","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.neuropharm.2021.108719_bib59","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.nbd.2008.12.017","article-title":"Glutamate toxicity in the striatum of the R6\/2 Huntington's disease transgenic mice is age-dependent and correlates with decreased levels of glutamate transporters","volume":"34","author":"Estrada-S\u00e1nchez","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2021.108719_bib60","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1093\/hmg\/ddq212","article-title":"In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects","volume":"19","author":"Faideau","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2021.108719_bib61","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/375599a0","article-title":"An excitatory amino-acid transporter with properties of a ligand-gated chloride channel","volume":"375","author":"Fairman","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2021.108719_bib62","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1111\/j.1471-4159.1992.tb10068.x","article-title":"Glutamate metabolism in rat cortical astrocyte cultures","volume":"58","author":"Farinelli","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2021.108719_bib63","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1177\/1533317511421780","article-title":"Brain glutamate levels are decreased in Alzheimer's disease: a magnetic resonance spectroscopy study","volume":"26","author":"Fayed","year":"2011","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.1016\/j.neuropharm.2021.108719_bib64","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/1073858407308518","article-title":"Regulation of synaptic transmission by ambient extracellular glutamate","volume":"14","author":"Featherstone","year":"2008","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neuropharm.2021.108719_bib65","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1042\/bj1060401","article-title":"The distribution of glutamate decarboxylase and aspartate transaminase in subcellular fractions of rat and Guinea-pig brain","volume":"106","author":"Fonnum","year":"1968","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuropharm.2021.108719_bib66","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1471-4159.2012.07933.x","article-title":"Deletion of glutamate dehydrogenase 1 (Glud1) in the central nervous system affects glutamate handling without altering synaptic transmission","volume":"123","author":"Frigerio","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2021.108719_bib67","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.neuroscience.2008.08.043","article-title":"A quantitative assessment of glutamate uptake into hippocampal synaptic terminals and astrocytes: new insights into a neuronal role for excitatory amino acid transporter 2 (EAAT2)","volume":"157","author":"Furness","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2021.108719_bib68","doi-asserted-by":"crossref","first-page":"18275","DOI":"10.1523\/JNEUROSCI.3305-11.2011","article-title":"Co-compartmentalization of the astroglial glutamate transporter, GLT-1, with glycolytic enzymes and mitochondria","volume":"31","author":"Genda","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108719_bib69","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1474-4422(18)30028-0","article-title":"Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study","volume":"17","author":"Gordon","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2021.108719_bib70","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.bbadis.2016.06.007","article-title":"Metabolic signatures of Huntington's disease (HD): (1)H NMR analysis of the polar metabolome in post-mortem human brain","volume":"1862","author":"Graham","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2021.108719_bib71","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1001\/archneur.1986.00520100062016","article-title":"The role of glutamate in neurotransmission and in neurologic disease","volume":"43","author":"Greenamyre","year":"1986","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108719_bib72","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0197-4580(89)90143-7","article-title":"Excitatory amino acids and Alzheimer's disease","volume":"10","author":"Greenamyre","year":"1989","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2021.108719_bib73","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0301-0082(96)00006-8","article-title":"Bioenergetics and glutamate excitotoxicity","volume":"48","author":"Greene","year":"1996","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2021.108719_bib74","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s10072-013-1289-9","article-title":"Alzheimer's disease: amino acid levels and brain metabolic status","volume":"34","author":"Gueli","year":"2013","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2021.108719_bib75","doi-asserted-by":"crossref","first-page":"13420","DOI":"10.1038\/ncomms13420","article-title":"Coupled binding mechanism of three sodium ions and aspartate in the glutamate transporter homologue Glt(Tk)","volume":"7","author":"Guskov","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2021.108719_bib76","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.neuron.2012.08.019","article-title":"Synaptic energy use and supply","volume":"75","author":"Harris","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2021.108719_bib77","doi-asserted-by":"crossref","first-page":"27715","DOI":"10.1074\/jbc.271.44.27715","article-title":"Brain glutamate transporter proteins form homomultimers","volume":"271","author":"Haugeto","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2021.108719_bib78","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jns.2018.06.005","article-title":"Tau clearance improves astrocytic function and brain glutamate-glutamine cycle","volume":"391","author":"Hebron","year":"2018","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2021.108719_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050717","article-title":"Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington's disease","volume":"7","author":"Heikkinen","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.neuropharm.2021.108719_bib80","doi-asserted-by":"crossref","first-page":"10168","DOI":"10.1523\/JNEUROSCI.0524-15.2015","article-title":"Is aspartate an excitatory neurotransmitter?","volume":"35","author":"Herring","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108719_bib81","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/jcbfm.2010.199","article-title":"Brain glutamine synthesis requires neuronal aspartate: a commentary","volume":"31","author":"Hertz","year":"2011","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.neuropharm.2021.108719_bib82","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fendo.2013.00059","article-title":"The glutamate-glutamine (GABA) cycle: importance of late postnatal development and potential reciprocal interactions between biosynthesis and degradation","volume":"4","author":"Hertz","year":"2013","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.neuropharm.2021.108719_bib83","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-3-319-45096-4_2","article-title":"Glucose, lactate, beta-hydroxybutyrate, acetate, GABA, and succinate as substrates for synthesis of glutamate and GABA in the glutamine-glutamate\/GABA cycle","volume":"13","author":"Hertz","year":"2016","journal-title":"Adv Neurobiol"},{"key":"10.1016\/j.neuropharm.2021.108719_bib84","series-title":"Model System of Development and Aging of the Nervous System","first-page":"19","article-title":"Primary cultures of GABAergic and glutamatergic neurons as model systems to study neurotransmitter functions","author":"Hertz","year":"1987"},{"key":"10.1016\/j.neuropharm.2021.108719_bib85","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/BF00972489","article-title":"Glutaminase in neurons and astrocytes cultured from mouse brain: kinetic properties and effects of phosphate, glutamate, and ammonia","volume":"13","author":"Hogstad","year":"1988","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2021.108719_bib86","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1177\/0271678X17714680","article-title":"Glutamate dehydrogenase is essential to sustain neuronal oxidative energy metabolism during stimulation","volume":"38","author":"Hohnholt","year":"2018","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.neuropharm.2021.108719_bib87","doi-asserted-by":"crossref","first-page":"6000","DOI":"10.1523\/JNEUROSCI.5347-11.2012","article-title":"The density of EAAC1 (EAAT3) glutamate transporters expressed by neurons in the mammalian CNS","volume":"32","author":"Holmseth","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108719_bib88","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.celrep.2017.10.097","article-title":"Spatiotemporal proteomic profiling of huntington's disease inclusions reveals widespread loss of protein function","volume":"21","author":"Hosp","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2021.108719_bib89","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.nbd.2010.05.027","article-title":"Palmitoylation and function of glial glutamate transporter-1 is reduced in the YAC128 mouse model of Huntington disease","volume":"40","author":"Huang","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2021.108719_bib90","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3233\/JAD-142970","article-title":"Regional increase in the expression of the BCAT proteins in Alzheimer's disease brain: implications in glutamate toxicity","volume":"45","author":"Hull","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neuropharm.2021.108719_bib91","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuint.2017.10.014","article-title":"Distribution of the branched-chain \u03b1-ketoacid dehydrogenase complex E1\u03b1 subunit and glutamate dehydrogenase in the human brain and their role in neuro-metabolism","volume":"112","author":"Hull","year":"2018","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2021.108719_bib92","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3233\/JAD-2007-11113","article-title":"Alterations in expression of glutamatergic transporters and receptors in sporadic Alzheimer's disease","volume":"11","author":"Jacob","year":"2007","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neuropharm.2021.108719_bib93","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1523\/JNEUROSCI.3693-15.2016","article-title":"Dysfunctional calcium and glutamate signaling in striatal astrocytes from huntington's disease model mice","volume":"36","author":"Jiang","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108719_bib94","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41591-020-0815-6","article-title":"Large-scale proteomic analysis of Alzheimer\u2019s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation","volume":"26","author":"Johnson","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2021.108719_bib95","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neuron.2010.09.002","article-title":"Metabolic control of vesicular glutamate transport and release","volume":"68","author":"Juge","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2021.108719_bib96","doi-asserted-by":"crossref","first-page":"9192","DOI":"10.1523\/JNEUROSCI.1198-07.2007","article-title":"Excitatory synaptic transmission persists independently of the glutamate-glutamine cycle","volume":"27","author":"Kam","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108719_bib97","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/360467a0","article-title":"Primary structure and functional characterization of a high-affinity glutamate transporter","volume":"360","author":"Kanai","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2021.108719_bib98","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.celrep.2015.09.003","article-title":"GDH-dependent glutamate oxidation in the brain dictates peripheral energy substrate distribution","volume":"13","author":"Karaca","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2021.108719_bib99","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.tins.2017.05.002","article-title":"Unravelling and exploiting astrocyte dysfunction in huntington's disease","volume":"40","author":"Khakh","year":"2017","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108719_bib100","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11064-018-2467-1","article-title":"Glutamate dehydrogenase as a neuroprotective target against neurodegeneration","volume":"44","author":"Kim","year":"2019","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2021.108719_bib101","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1042\/AN20130017","article-title":"Astrocytes and glutamate homoeostasis in Alzheimer's disease: a decrease in glutamine synthetase, but not in glutamate transporter-1, in the prefrontal cortex","volume":"5","author":"Kulijewicz-Nawrot","year":"2013","journal-title":"ASN Neuro"},{"key":"10.1016\/j.neuropharm.2021.108719_bib102","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/jnr.10041","article-title":"Kinetics and localization of brain phosphate activated glutaminase","volume":"66","author":"Kvamme","year":"2001","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2021.108719_bib103","doi-asserted-by":"crossref","DOI":"10.1111\/gbb.12636","article-title":"Glutamate dehydrogenase deficiency disrupts glutamate homeostasis in hippocampus and prefrontal cortex and impairs recognition memory","volume":"19","author":"Lander","year":"2020","journal-title":"Gene Brain Behav."},{"key":"10.1016\/j.neuropharm.2021.108719_bib104","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.neuint.2018.04.015","article-title":"Huntington's disease pattern of transcriptional dysregulation in the absence of mutant huntingtin is produced by knockout of neuronal GLT-1","volume":"123","author":"Laprairie","year":"2019","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2021.108719_bib105","doi-asserted-by":"crossref","first-page":"8751","DOI":"10.1523\/JNEUROSCI.18-21-08751.1998","article-title":"The number of glutamate transporter subtype molecules at glutamatergic synapses: chemical and stereological quantification in young adult rat brain","volume":"18","author":"Lehre","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108719_bib106","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1523\/JNEUROSCI.15-03-01835.1995","article-title":"Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations","volume":"15","author":"Lehre","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108719_bib107","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/978-3-319-45096-4_8","article-title":"The glutamine transporters and their role in the glutamate\/GABA-glutamine cycle","volume":"13","author":"Leke","year":"2016","journal-title":"Adv Neurobiol"},{"key":"10.1016\/j.neuropharm.2021.108719_bib108","doi-asserted-by":"crossref","first-page":"9620","DOI":"10.1523\/JNEUROSCI.18-23-09620.1998","article-title":"Stoichiometry of the glial glutamate transporter GLT-1 expressed inducibly in a Chinese hamster ovary cell line selected for low endogenous Na+-dependent glutamate uptake","volume":"18","author":"Levy","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108719_bib109","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3389\/fnins.2015.00469","article-title":"Chronic glutamate toxicity in neurodegenerative diseases-what is the evidence?","volume":"9","author":"Lewerenz","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108719_bib110","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.neuron.2009.05.012","article-title":"Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake","volume":"62","author":"Li","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2021.108719_bib111","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.neuint.2010.10.017","article-title":"The structure and allosteric regulation of glutamate dehydrogenase","volume":"59","author":"Li","year":"2011","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2021.108719_bib112","doi-asserted-by":"crossref","first-page":"9882","DOI":"10.18632\/aging.103253","article-title":"Systematic metabolic analysis of potential target, therapeutic drug, diagnostic method and animal model applicability in three neurodegenerative diseases","volume":"12","author":"Li","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.neuropharm.2021.108719_bib113","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2021.108719_bib114","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1006\/nbdi.2001.0430","article-title":"Impaired glutamate uptake in the R6 Huntington's disease transgenic mice","volume":"8","author":"Li\u00e9vens","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2021.108719_bib115","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJM199403033300907","article-title":"Excitatory amino acids as a final common pathway for neurologic disorders","volume":"330","author":"Lipton","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2021.108719_bib116","doi-asserted-by":"crossref","first-page":"12255","DOI":"10.1523\/JNEUROSCI.3404-07.2007","article-title":"The transcriptome and metabolic gene signature of protoplasmic astrocytes in the adult murine cortex","volume":"27","author":"Lovatt","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108719_bib117","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.cmet.2015.10.010","article-title":"In vivo evidence for a lactate gradient from astrocytes to neurons","volume":"23","author":"M\u00e4chler","year":"2016","journal-title":"Cell Metabol."},{"key":"10.1016\/j.neuropharm.2021.108719_bib118","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrn.2018.19","article-title":"Lactate in the brain: from metabolic end-product to signalling molecule","volume":"19","author":"Magistretti","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108719_bib119","article-title":"Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: a targeted metabolomic and transcriptomic study","volume":"17","author":"Mahajan","year":"2020","journal-title":"PLoS Med."},{"key":"10.1016\/j.neuropharm.2021.108719_bib120","doi-asserted-by":"crossref","first-page":"15056","DOI":"10.1038\/nrdp.2015.56","article-title":"Alzheimer's disease","volume":"1","author":"Masters","year":"2015","journal-title":"Nat Rev Dis Prim."},{"key":"10.1016\/j.neuropharm.2021.108719_bib121","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/jnr.20353","article-title":"Molecular basis of human glutamate dehydrogenase regulation under changing energy demands","volume":"79","author":"Mastorodemos","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2021.108719_bib122","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s11064-018-2575-y","article-title":"Localization of human glutamate dehydrogenases provides insights into their metabolic role and their involvement in disease processes","volume":"44","author":"Mathioudakis","year":"2019","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2021.108719_bib123","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.neuroscience.2008.08.022","article-title":"Amyloid-beta peptide decreases glutamate uptake in cultured astrocytes: involvement of oxidative stress and mitogen-activated protein kinase cascades","volume":"156","author":"Matos","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2021.108719_bib124","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nature02621","article-title":"Pathways towards and away from Alzheimer's disease","volume":"430","author":"Mattson","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2021.108719_bib125","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1002\/jnr.21444","article-title":"The glutamate-glutamine cycle is not stoichiometric: fates of glutamate in brain","volume":"85","author":"McKenna","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2021.108719_bib126","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1007\/s11064-012-0901-3","article-title":"Substrate competition studies demonstrate oxidative metabolism of glucose, glutamate, glutamine, lactate and 3-hydroxybutyrate in cortical astrocytes from rat brain","volume":"37","author":"McKenna","year":"2012","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2021.108719_bib127","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3389\/fendo.2013.00191","article-title":"Glutamate pays its own way in astrocytes","volume":"4","author":"McKenna","year":"2013","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.neuropharm.2021.108719_bib128","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000111351","article-title":"Regulation of energy metabolism in synaptic terminals and cultured rat brain astrocytes: differences revealed using aminooxyacetate","volume":"15","author":"McKenna","year":"1993","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108719_bib129","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1046\/j.1471-4159.1996.66010386.x","article-title":"Exogenous glutamate concentration regulates the metabolic fate of glutamate in astrocytes","volume":"66","author":"McKenna","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2021.108719_bib130","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000111431","article-title":"New insights into the compartmentation of glutamate and glutamine in cultured rat brain astrocytes","volume":"18","author":"McKenna","year":"1996","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108719_bib131","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.bcp.2005.10.011","article-title":"Neuronal and astrocytic shuttle mechanisms for cytosolic-mitochondrial transfer of reducing equivalents: current evidence and pharmacological tools","volume":"71","author":"McKenna","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108719_bib132","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/jnr.23908","article-title":"Glutamate oxidation in astrocytes: roles of glutamate dehydrogenase and aminotransferases","volume":"94","author":"McKenna","year":"2016","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2021.108719_bib133","doi-asserted-by":"crossref","first-page":"4847","DOI":"10.1523\/JNEUROSCI.0894-18.2019","article-title":"Deletion of neuronal GLT-1 in mice reveals its role in synaptic glutamate homeostasis and mitochondrial function","volume":"39","author":"McNair","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108719_bib134","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1007\/s11064-020-03000-7","article-title":"Conditional knockout of GLT-1 in neurons leads to alterations in aspartate homeostasis and synaptic mitochondrial metabolism in striatum and Hippocampus","volume":"45","author":"McNair","year":"2020","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2021.108719_bib135","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.neuint.2011.03.003","article-title":"Neuronal Glud1 (glutamate dehydrogenase 1) over-expressing mice: increased glutamate formation and synaptic release, loss of synaptic activity, and adaptive changes in genomic expression","volume":"59","author":"Michaelis","year":"2011","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2021.108719_bib136","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.neuroscience.2008.02.004","article-title":"Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6\/2 mouse","volume":"153","author":"Miller","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2021.108719_bib137","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1172\/JCI45691","article-title":"Energy deficit in Huntington disease: why it matters","volume":"121","author":"Mochel","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuropharm.2021.108719_bib138","doi-asserted-by":"crossref","first-page":"e647","DOI":"10.1371\/journal.pone.0000647","article-title":"Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression","volume":"2","author":"Mochel","year":"2007","journal-title":"PloS One"},{"key":"10.1016\/j.neuropharm.2021.108719_bib139","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/archneurol.2010.358","article-title":"Validation of plasma branched chain amino acids as biomarkers in Huntington disease","volume":"68","author":"Mochel","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108719_bib140","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3233\/JAD-2011-110503","article-title":"GLT-1 loss Accelerates cognitive deficit onset in an Alzheimer's disease animal model","volume":"26","author":"Mookherjee","year":"2011","journal-title":"J. Alzheim. Dis."},{"issue":"1802","key":"10.1016\/j.neuropharm.2021.108719_bib141","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bbadis.2009.10.006","article-title":"Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology","author":"Moreira","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2021.108719_bib142","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s11064-010-0291-3","article-title":"Aspartate release and signalling in the hippocampus","volume":"36","author":"Nadler","year":"2011","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2021.108719_bib143","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/260538a0","article-title":"Aspartate and glutamate as possible transmitters of excitatory hippocampal afferents","volume":"260","author":"Nadler","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2021.108719_bib144","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1471-4159.1985.tb07118.x","article-title":"Characterization of glutamate uptake into synaptic vesicles","volume":"44","author":"Naito","year":"1985","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2021.108719_bib145","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.bbr.2016.06.002","article-title":"Hippocampal proteomics defines pathways associated with memory decline and resilience in normal aging and Alzheimer's disease mouse models","volume":"322","author":"Neuner","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2021.108719_bib146","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/jcbfm.2012.212","article-title":"Glutamate metabolism is impaired in transgenic mice with tau hyperphosphorylation","volume":"33","author":"Nilsen","year":"2013","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.neuropharm.2021.108719_bib147","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/jcbfm.2014.37","article-title":"Neuronal and astrocytic metabolism in a transgenic rat model of Alzheimer's disease","volume":"34","author":"Nilsen","year":"2014","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.neuropharm.2021.108719_bib148","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1002\/glia.22895","article-title":"Dysfunctional TCA-cycle metabolism in glutamate dehydrogenase deficient astrocytes","volume":"63","author":"Nissen","year":"2015","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2021.108719_bib149","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0006-8993(79)90071-4","article-title":"Fine structural localization of glutamine synthetase in astrocytes of rat brain","volume":"161","author":"Norenberg","year":"1979","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2021.108719_bib150","doi-asserted-by":"crossref","DOI":"10.1126\/science.aav9518","article-title":"Amyloid \u03b2 oligomers constrict human capillaries in Alzheimer's disease via signaling to pericytes","volume":"365","author":"Nortley","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2021.108719_bib151","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.stemcr.2017.10.016","article-title":"PSEN1 mutant iPSC-derived model reveals severe astrocyte pathology in Alzheimer's disease","volume":"9","author":"Oksanen","year":"2017","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.neuropharm.2021.108719_bib152","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1750-1326-6-55","article-title":"Age-dependent decrease in glutamine synthetase expression in the hippocampal astroglia of the triple transgenic Alzheimer's disease mouse model: mechanism for deficient glutamatergic transmission?","volume":"6","author":"Olabarria","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuropharm.2021.108719_bib153","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1111\/j.1742-4658.2008.06612.x","article-title":"Increased glucose metabolism and ATP level in brain tissue of Huntington's disease transgenic mice","volume":"275","author":"Ol\u00e1h","year":"2008","journal-title":"FEBS J."},{"key":"10.1016\/j.neuropharm.2021.108719_bib154","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.02.032","article-title":"Glutamate transporters: gene expression regulation and signaling properties","volume":"161","author":"Olivares-Ba\u00f1uelos","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2021.108719_bib155","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/sj.jcbfm.9600400","article-title":"Glutamate is preferred over glutamine for intermediary metabolism in cultured cerebellar neurons","volume":"27","author":"Olstad","year":"2007","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.neuropharm.2021.108719_bib156","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/glia.23294","article-title":"The cystine-glutamate exchanger (xCT, Slc7a11) is expressed in significant concentrations in a subpopulation of astrocytes in the mouse brain","volume":"66","author":"Ottestad-Hansen","year":"2018","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2021.108719_bib157","doi-asserted-by":"crossref","first-page":"11273","DOI":"10.1523\/JNEUROSCI.3564-04.2004","article-title":"Neuroglial metabolism in the awake rat brain: CO2 fixation increases with brain activity","volume":"24","author":"\u00d6z","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108719_bib158","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1254\/jjp.77.1","article-title":"Glutamate transport and storage in synaptic vesicles","volume":"77","author":"Ozkan","year":"1998","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108719_bib159","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1021\/acs.jproteome.5b01020","article-title":"Unbiased metabolomic investigation of Alzheimer's disease brain points to dysregulation of mitochondrial aspartate metabolism","volume":"15","author":"Paglia","year":"2016","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.neuropharm.2021.108719_bib160","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/jnr.23568","article-title":"Glucose replaces glutamate as energy substrate to fuel glutamate uptake in glutamate dehydrogenase-deficient astrocytes","volume":"93","author":"Paj\u0119cka","year":"2015","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2021.108719_bib161","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/jcbfm.2010.146","article-title":"Brain glutamine synthesis requires neuronal-born aspartate as amino donor for glial glutamate formation","volume":"31","author":"Pardo","year":"2011","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.neuropharm.2021.108719_bib162","doi-asserted-by":"crossref","first-page":"11251","DOI":"10.1038\/ncomms11251","article-title":"Real-time imaging of glutamate clearance reveals normal striatal uptake in Huntington disease mouse models","volume":"7","author":"Parsons","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2021.108719_bib163","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.bbadis.2016.06.002","article-title":"Metabolite mapping reveals severe widespread perturbation of multiple metabolic processes in Huntington's disease human brain","volume":"1862","author":"Patassini","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2021.108719_bib164","doi-asserted-by":"crossref","first-page":"10625","DOI":"10.1073\/pnas.91.22.10625","article-title":"Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization","volume":"91","author":"Pellerin","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2021.108719_bib165","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neuroimage.2016.06.023","article-title":"In vivo imaging of brain glutamate defects in a knock-in mouse model of Huntington's disease","volume":"139","author":"P\u00e9pin","year":"2016","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2021.108719_bib166","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/mp.2016.33","article-title":"Age and Alzheimer's disease gene expression profiles reversed by the glutamate modulator riluzole","volume":"22","author":"Pereira","year":"2017","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2021.108719_bib167","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0140-6736(69)92068-6","article-title":"Plasma-aminoacid levels in Huntington's chorea","volume":"1","author":"Perry","year":"1969","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2021.108719_bib168","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1111\/ejn.12202","article-title":"Decreased expression of GLT-1 in the R6\/2 model of Huntington's disease does not worsen disease progression","volume":"38","author":"Petr","year":"2013","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108719_bib169","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1523\/JNEUROSCI.4255-14.2015","article-title":"Conditional deletion of the glutamate transporter GLT-1 reveals that astrocytic GLT-1 protects against fatal epilepsy while neuronal GLT-1 contributes significantly to glutamate uptake into synaptosomes","volume":"35","author":"Petr","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108719_bib170","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/360464a0","article-title":"Cloning and expression of a rat brain L-glutamate transporter","volume":"360","author":"Pines","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2021.108719_bib171","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.cmet.2019.03.004","article-title":"Metabolic reprogramming in astrocytes distinguishes region-specific neuronal susceptibility in huntington mice","volume":"29","author":"Polyzos","year":"2019","journal-title":"Cell Metabol."},{"key":"10.1016\/j.neuropharm.2021.108719_bib172","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1474-9726.2010.00593.x","article-title":"Reduction in glutamate uptake is associated with extrasynaptic NMDA and metabotropic glutamate receptor activation at the hippocampal CA1 synapse of aged rats","volume":"9","author":"Potier","year":"2010","journal-title":"Aging Cell"},{"key":"10.1016\/j.neuropharm.2021.108719_bib173","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152342","article-title":"Identification of differentially expressed genes through integrated study of Alzheimer's disease affected brain regions","volume":"11","author":"Puthiyedth","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.neuropharm.2021.108719_bib174","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer's disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2021.108719_bib175","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neuroscience.2011.08.052","article-title":"Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function","volume":"198","author":"Raymond","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2021.108719_bib176","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuint.2016.04.010","article-title":"GLT-1: the elusive presynaptic glutamate transporter","volume":"98","author":"Rimmele","year":"2016","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2021.108719_bib177","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0197-0186(99)00150-3","article-title":"Neuronal expression of glutamine synthetase in Alzheimer's disease indicates a profound impairment of metabolic interactions with astrocytes","volume":"36","author":"Robinson","year":"2000","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2021.108719_bib178","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-3-319-55769-4_8","article-title":"Glutamine\/glutamate transporters in glial cells: much more than participants of a metabolic shuttle","volume":"16","author":"Rodr\u00edguez","year":"2017","journal-title":"Adv Neurobiol"},{"key":"10.1016\/j.neuropharm.2021.108719_bib179","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.brainresbull.2016.12.013","article-title":"Molecular and cellular physiology of sodium-dependent glutamate transporters","volume":"136","author":"Rose","year":"2018","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2021.108719_bib180","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1523\/JNEUROSCI.12-01-00056.1992","article-title":"Glutamate uptake disguises neurotoxic potency of glutamate agonists in cerebral cortex in dissociated cell culture","volume":"12","author":"Rosenberg","year":"1992","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108719_bib181","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2021.108719_bib182","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/nbm.1772","article-title":"13C MRS studies of neuroenergetics and neurotransmitter cycling in humans","volume":"24","author":"Rothman","year":"2011","journal-title":"NMR Biomed."},{"key":"10.1016\/j.neuropharm.2021.108719_bib183","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199205283262204","article-title":"Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis","volume":"326","author":"Rothstein","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2021.108719_bib184","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0896-6273(94)90038-8","article-title":"Localization of neuronal and glial glutamate transporters","volume":"13","author":"Rothstein","year":"1994","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2021.108719_bib185","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1073\/pnas.1616413114","article-title":"Direct visualization of glutamate transporter elevator mechanism by high-speed AFM","volume":"114","author":"Ruan","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2021.108719_bib186","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.neurobiolaging.2009.05.002","article-title":"Reduced hippocampal glutamate in Alzheimer disease","volume":"32","author":"Rupsingh","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2021.108719_bib187","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-021-01068-3","article-title":"Brain cells derived from Alzheimer\u2019s disease patients have multiple specific innate abnormalities in energy metabolism","author":"Ryu","year":"2021","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2021.108719_bib188","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1471-4159.1965.tb06766.x","article-title":"Subcellular distribution OF the enzymes OF the glutamic acid, glutamine and \u03b3-AMINOBUTYRIC acid cycles IN rat brain*","volume":"12","author":"Salganicoff","year":"1965","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2021.108719_bib189","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1016\/j.celrep.2017.11.009","article-title":"Amyloid accumulation drives proteome-wide alterations in mouse models of Alzheimer's disease-like pathology","volume":"21","author":"Savas","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2021.108719_bib190","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fendo.2013.00102","article-title":"Astrocytic control of biosynthesis and turnover of the neurotransmitters glutamate and GABA","volume":"4","author":"Schousboe","year":"2013","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.neuropharm.2021.108719_bib191","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-3-319-08894-5_2","article-title":"Glutamate metabolism in the brain focusing on astrocytes","volume":"11","author":"Schousboe","year":"2014","journal-title":"Adv Neurobiol"},{"key":"10.1016\/j.neuropharm.2021.108719_bib192","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/jnr.24402","article-title":"Astrocytic pyruvate carboxylation: status after 35 years","volume":"97","author":"Schousboe","year":"2019","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2021.108719_bib193","doi-asserted-by":"crossref","first-page":"14581","DOI":"10.1523\/JNEUROSCI.4845-09.2009","article-title":"Neuronal transporters regulate glutamate clearance, NMDA receptor activation, and synaptic plasticity in the hippocampus","volume":"29","author":"Scimemi","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108719_bib194","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.1523\/JNEUROSCI.5274-12.2013","article-title":"Amyloid-\u03b21-42 slows clearance of synaptically released glutamate by mislocalizing astrocytic GLT-1","volume":"33","author":"Scimemi","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108719_bib195","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2010.03.008","article-title":"Glutamate transporter variants reduce glutamate uptake in Alzheimer's disease","volume":"32","author":"Scott","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2021.108719_bib196","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1126\/science.aay5188","article-title":"Early network dysfunction in Alzheimer's disease","volume":"365","author":"Selkoe","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2021.108719_bib197","doi-asserted-by":"crossref","first-page":"6372","DOI":"10.1523\/JNEUROSCI.22-15-06372.2002","article-title":"A neuronal glutamate transporter contributes to neurotransmitter GABA synthesis and epilepsy","volume":"22","author":"Sepkuty","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108719_bib198","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1038\/nn.4160","article-title":"Cell type\u2013 and brain region\u2013resolved mouse brain proteome","volume":"18","author":"Sharma","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108719_bib199","doi-asserted-by":"crossref","first-page":"21800","DOI":"10.1073\/pnas.1903566116","article-title":"Divergent roles of astrocytic versus neuronal EAAT2 deficiency on cognition and overlap with aging and Alzheimer's molecular signatures","volume":"116","author":"Sharma","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2021.108719_bib200","doi-asserted-by":"crossref","first-page":"8235","DOI":"10.1073\/pnas.96.14.8235","article-title":"Determination of the rate of the glutamate\/glutamine cycle in the human brain by in vivo 13C NMR","volume":"96","author":"Shen","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2021.108719_bib201","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1073\/pnas.95.1.316","article-title":"Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity","volume":"95","author":"Sibson","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2021.108719_bib202","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1016\/j.celrep.2018.04.052","article-title":"Integrative characterization of the R6\/2 mouse model of huntington's disease reveals dysfunctional astrocyte metabolism","volume":"23","author":"Skotte","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2021.108719_bib203","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.neuint.2012.04.014","article-title":"siRNA knock down of glutamate dehydrogenase in astrocytes affects glutamate metabolism leading to extensive accumulation of the neuroactive amino acids glutamate and aspartate","volume":"61","author":"Skytt","year":"2012","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2021.108719_bib204","doi-asserted-by":"crossref","first-page":"10540","DOI":"10.1073\/pnas.88.23.10540","article-title":"Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease","volume":"88","author":"Smith","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2021.108719_bib205","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/jnc.12812","article-title":"Glutamate synthesis has to be matched by its degradation - where do all the carbons go?","volume":"131","author":"Sonnewald","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2021.108719_bib206","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1471-4159.1993.tb03641.x","article-title":"Metabolism of [U-13C]glutamate in astrocytes studied by 13C NMR spectroscopy: incorporation of more label into lactate than into glutamine demonstrates the importance of the tricarboxylic acid cycle","volume":"61","author":"Sonnewald","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2021.108719_bib207","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/BF02532408","article-title":"MRS study of glutamate metabolism in cultured neurons\/glia","volume":"21","author":"Sonnewald","year":"1996","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2021.108719_bib208","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s11064-017-2261-5","article-title":"Branched-chain amino acids and brain metabolism","volume":"42","author":"Sperringer","year":"2017","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2021.108719_bib209","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2010.09.018","article-title":"Reactive astrocytes give neurons less support: implications for Alzheimer's disease","volume":"33","author":"Steele","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2021.108719_bib210","doi-asserted-by":"crossref","first-page":"10955","DOI":"10.1073\/pnas.89.22.10955","article-title":"Structure, expression, and functional analysis of a Na(+)-dependent glutamate\/aspartate transporter from rat brain","volume":"89","author":"Storck","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2021.108719_bib211","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1212\/WNL.0b013e3181fc27e4","article-title":"Magnetic resonance spectroscopy biomarkers in premanifest and early Huntington disease","volume":"75","author":"Sturrock","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2021.108719_bib212","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.cell.2011.02.018","article-title":"Astrocyte-neuron lactate transport is required for long-term memory formation","volume":"144","author":"Suzuki","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2021.108719_bib213","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E","article-title":"Biochemical abnormalities and excitotoxicity in Huntington's disease brain","volume":"45","author":"Tabrizi","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108719_bib214","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1126\/science.276.5319.1699","article-title":"Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1","volume":"276","author":"Tanaka","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2021.108719_bib215","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.1172\/JCI69411","article-title":"Metabolic network as a progression biomarker of premanifest Huntington's disease","volume":"123","author":"Tang","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuropharm.2021.108719_bib216","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1523\/JNEUROSCI.0106-09.2010","article-title":"Glutamine is required for persistent epileptiform activity in the disinhibited neocortical brain slice","volume":"30","author":"Tani","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108719_bib217","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.neuron.2013.12.026","article-title":"A local glutamate-glutamine cycle sustains synaptic excitatory transmitter release","volume":"81","author":"Tani","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2021.108719_bib218","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nn.4532","article-title":"Developmental alterations in Huntington's disease neural cells and pharmacological rescue in cells and mice","volume":"20","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108719_bib219","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3233\/JAD-2011-111502","article-title":"Impaired glutamatergic and GABAergic function at early age in A\u03b2PPswe-PS1dE9 mice: implications for Alzheimer's disease","volume":"28","author":"Tiwari","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neuropharm.2021.108719_bib220","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3233\/JAD-122449","article-title":"Pyruvate carboxylase and pentose phosphate fluxes are reduced in AbetaPP-PS1 mouse model of Alzheimer's disease: a (1)(3)C NMR study","volume":"41","author":"Tiwari","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neuropharm.2021.108719_bib221","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/j.1471-4159.2006.04323.x","article-title":"Neurochemical changes in Huntington R6\/2 mouse striatum detected by in vivo 1H NMR spectroscopy","volume":"100","author":"Tkac","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2021.108719_bib222","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nn.3691","article-title":"Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington's disease model mice","volume":"17","author":"Tong","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108719_bib223","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1021\/pr050244o","article-title":"Metabolic characterization of the R6\/2 transgenic mouse model of Huntington's disease by high-resolution MAS 1H NMR spectroscopy","volume":"5","author":"Tsang","year":"2006","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.neuropharm.2021.108719_bib224","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175369","article-title":"Metabolic changes and inflammation in cultured astrocytes from the 5xFAD mouse model of Alzheimer's disease: Alleviation by pantethine","volume":"12","author":"van Gijsel-Bonnello","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.neuropharm.2021.108719_bib225","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/glia.23808","article-title":"AMP-activated protein kinase (AMPK) regulates astrocyte oxidative metabolism by balancing TCA cycle dynamics","volume":"68","author":"Voss","year":"2020","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2021.108719_bib226","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.646291","article-title":"Glutamate dehydrogenase is important for ammonia fixation and amino acid homeostasis in brain during hyperammonemia","volume":"15","author":"Voss","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108719_bib227","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.neuint.2006.10.007","article-title":"Glutamate-glutamine cycling in Alzheimer's disease","volume":"50","author":"Walton","year":"2007","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2021.108719_bib228","article-title":"Synaptosomal mitochondrial dysfunction in 5xFAD mouse model of Alzheimer's disease","volume":"11","author":"Wang","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.neuropharm.2021.108719_bib229","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1471-4159.1983.tb08058.x","article-title":"Glutamine and glucose as precursors of transmitter amino acids: ex vivo studies","volume":"40","author":"Ward","year":"1983","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2021.108719_bib230","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev.pa.21.040181.001121","article-title":"Excitatory amino acid transmitters","volume":"21","author":"Watkins","year":"1981","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2021.108719_bib231","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/(SICI)1098-1136(199606)17:2<160::AID-GLIA7>3.0.CO;2-6","article-title":"Evaluation of the importance of transamination versus deamination in astrocytic metabolism of [U-13C]glutamate","volume":"17","author":"Westergaard","year":"1996","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2021.108719_bib232","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fendo.2013.00123","article-title":"Inhibitors of glutamate dehydrogenase block sodium-dependent glutamate uptake in rat brain membranes","volume":"4","author":"Whitelaw","year":"2013","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.neuropharm.2021.108719_bib233","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104963","article-title":"The contribution of glial cells to Huntington's disease pathogenesis","volume":"143","author":"Wilton","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2021.108719_bib234","doi-asserted-by":"crossref","first-page":"11726","DOI":"10.1074\/jbc.271.20.11726","article-title":"Regulation of glutamate transport into synaptic vesicles by chloride and proton gradient","volume":"271","author":"Wolosker","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2021.108719_bib235","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.bbadis.2016.03.001","article-title":"Graded perturbations of metabolism in multiple regions of human brain in Alzheimer's disease: snapshot of a pervasive metabolic disorder","volume":"1862","author":"Xu","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2021.108719_bib236","doi-asserted-by":"crossref","first-page":"14670","DOI":"10.1073\/pnas.0903563106","article-title":"Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease","volume":"106","author":"Yao","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2021.108719_bib237","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/nature03018","article-title":"Structure of a glutamate transporter homologue from Pyrococcus horikoshii","volume":"431","author":"Yernool","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2021.108719_bib238","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1471-4159.1982.tb11482.x","article-title":"Metabolic fate of 14C-labeled glutamate in astrocytes in primary cultures","volume":"39","author":"Yu","year":"1982","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2021.108719_bib239","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1111\/j.1471-4159.1983.tb00849.x","article-title":"Pyruvate carboxylase activity in primary cultures of astrocytes and neurons","volume":"41","author":"Yu","year":"1983","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2021.108719_bib240","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1177\/0271678X17708691","article-title":"Evaluating the gray and white matter energy budgets of human brain function","volume":"38","author":"Yu","year":"2018","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.neuropharm.2021.108719_bib241","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/(SICI)1098-1136(199709)21:1<92::AID-GLIA10>3.0.CO;2-W","article-title":"Brain metabolism of branched-chain amino acids","volume":"21","author":"Yudkoff","year":"1997","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2021.108719_bib242","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1074\/mcp.M800277-MCP200","article-title":"A large number of protein expression changes occur early in life and precede phenotype onset in a mouse model for huntington disease","volume":"8","author":"Zabel","year":"2009","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.neuropharm.2021.108719_bib243","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/jcbfm.2011.157","article-title":"Cortical metabolites as biomarkers in the R6\/2 model of Huntington's disease","volume":"32","author":"Zacharoff","year":"2012","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.neuropharm.2021.108719_bib244","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/jnr.10058","article-title":"Differential expression of glutamate dehydrogenase in cultured neurons and astrocytes from mouse cerebellum and cerebral cortex","volume":"66","author":"Zaganas","year":"2001","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2021.108719_bib245","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/383634a0","article-title":"Flux coupling in a neuronal glutamate transporter","volume":"383","author":"Zerangue","year":"1996","journal-title":"Nature"},{"issue":"Pt 2","key":"10.1016\/j.neuropharm.2021.108719_bib246","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1113\/jphysiol.1996.sp021393","article-title":"Interaction of L-cysteine with a human excitatory amino acid transporter","volume":"493","author":"Zerangue","year":"1996","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2021.108719_bib247","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3389\/fendo.2013.00165","article-title":"GABA and glutamate transporters in brain","volume":"4","author":"Zhou","year":"2013","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.neuropharm.2021.108719_bib248","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuint.2018.03.006","article-title":"Axon-terminals expressing EAAT2 (GLT-1; Slc1a2) are common in the forebrain and not limited to the hippocampus","volume":"123","author":"Zhou","year":"2019","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2021.108719_bib249","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1126\/science.aay0198","article-title":"A vicious cycle of beta amyloid-dependent neuronal hyperactivation","volume":"365","author":"Zott","year":"2019","journal-title":"Science"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390821002744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390821002744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:17:26Z","timestamp":1758439046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390821002744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":249,"alternative-id":["S0028390821002744"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108719","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glutamate metabolism and recycling at the excitatory synapse in health and neurodegeneration","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108719","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108719"}}